Evolent Health, Inc. ( EVH) - Key Metrics
EVH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $5.80 | -$0.25 | -$0.09 | -$0.21 |
| 2026Q1 | $4.43 | -$0.24 | -$0.01 | -$0.07 |
| 2025Q4 | $4.10 | -$3.76 | $0.43 | $0.36 |
| 2025Q3 | $4.20 | -$0.18 | $0.14 | $0.06 |
| 2025Q2 | $3.83 | -$0.17 | -$0.26 | -$0.34 |
EVH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.42 |
| 2026Q1 | 0% | -2.38 |
| 2025Q4 | 0% | -0.27 |
| 2025Q3 | -9.25% | -8.81 |
| 2025Q2 | -23.22% | -6.40 |
EVH
Price: $4.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.49 USD
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 198391
Ebitda: -6.2 millionMarket Capitalization: 485.9 million